291 related articles for article (PubMed ID: 28709570)
1. Systemic therapies in atopic dermatitis: The pipeline.
Renert-Yuval Y; Guttman-Yassky E
Clin Dermatol; 2017; 35(4):387-397. PubMed ID: 28709570
[TBL] [Abstract][Full Text] [Related]
2. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
Guttman-Yassky E; Krueger JG
Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
[TBL] [Abstract][Full Text] [Related]
3. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.
Brunner PM; Guttman-Yassky E; Leung DY
J Allergy Clin Immunol; 2017 Apr; 139(4S):S65-S76. PubMed ID: 28390479
[TBL] [Abstract][Full Text] [Related]
4. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for the treatment of atopic dermatitis.
Renert-Yuval Y; Guttman-Yassky E
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
[TBL] [Abstract][Full Text] [Related]
6. New pathogenic and therapeutic paradigms in atopic dermatitis.
Malajian D; Guttman-Yassky E
Cytokine; 2015 Jun; 73(2):311-8. PubMed ID: 25542094
[TBL] [Abstract][Full Text] [Related]
7. What's New in Atopic Dermatitis.
Renert-Yuval Y; Guttman-Yassky E
Dermatol Clin; 2019 Apr; 37(2):205-213. PubMed ID: 30850043
[TBL] [Abstract][Full Text] [Related]
8. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
9. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
[TBL] [Abstract][Full Text] [Related]
10. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.
Czarnowicki T; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol Pract; 2014; 2(4):371-9; quiz 380-1. PubMed ID: 25017523
[TBL] [Abstract][Full Text] [Related]
11. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
[TBL] [Abstract][Full Text] [Related]
12. New and emerging targeted systemic therapies: a new era for atopic dermatitis.
Lee DE; Clark AK; Tran KA; Shi VY
J Dermatolog Treat; 2018 Jun; 29(4):364-374. PubMed ID: 28853956
[TBL] [Abstract][Full Text] [Related]
13. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
Correa da Rosa J; Malajian D; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Khattri S; Ungar B; Finney R; Xu H; Zheng X; Estrada YD; Peng X; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Mar; 135(3):712-20. PubMed ID: 25583101
[TBL] [Abstract][Full Text] [Related]
14. A Therapeutic Renaissance - Emerging Treatments for Atopic Dermatitis.
Na CH; Baghoomian W; Simpson EL
Acta Derm Venereol; 2020 Jun; 100(12):adv00165. PubMed ID: 32419031
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab for off-label treatment of moderate to severe childhood atopic dermatitis.
Jorge E; Clark J
Cutis; 2018 Sep; 102(3):201-204. PubMed ID: 30372706
[TBL] [Abstract][Full Text] [Related]
16. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases.
Malik K; Guttman-Yassky E
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S62-S64. PubMed ID: 29273110
[TBL] [Abstract][Full Text] [Related]
17. Early-onset pediatric atopic dermatitis is characterized by T
Brunner PM; Israel A; Zhang N; Leonard A; Wen HC; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Wagner A; Zheng X; Estrada YD; Xu H; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2018 Jun; 141(6):2094-2106. PubMed ID: 29731129
[TBL] [Abstract][Full Text] [Related]
18. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
19. The translational revolution and use of biologics in patients with inflammatory skin diseases.
Noda S; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Feb; 135(2):324-36. PubMed ID: 25541257
[TBL] [Abstract][Full Text] [Related]
20. Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch.
Werfel T; Biedermann T
Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):446-52. PubMed ID: 26308331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
